Objectives In 2008, a national human papillomavirus (HPV) vaccination programme for
females was introduced in England using the bivalent vaccine (HPV16 and 18 only). In …

Background Condyloma acuminata currently affects around 1% of sexually active adults,
and its incidence is increasing. The coexistence of genital warts (GW) and certain cancers …

Objectives To estimate for the first time the incidence and healthcare resource utilisation
associated with genital warts (GW) in Australia prior to the human papillomavirus …

Objective Trends in occurrence of anogenital warts (AGWs) can provide early evidence of
human papillomavirus (HPV) vaccination programme impact on preventing HPV infection …

Abstract Background Although the United States Food and Drug Administration recently
approved the human papillomavirus (HPV) vaccine for individuals aged 27–45 years, the …

AIM: To investigate whether changes in rates of genital warts diagnosis at Auckland Sexual
Health Service (ASHS), pre and post the quadrivalent human papillomavirus (4vHPV) …

Background In 2008, British Columbia (BC) implemented a school-based quadrivalent
human papillomavirus (HPV-4) immunization program for girls born in 1994 or later. In 2015 …

Background To assess the impact of a quadrivalent human papillomavirus vaccine (4HPV)
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …

Human papillomavirus (HPV) infection acquisition is a necessary step in the development of
cervical cancer. No study has systematically quantified the rate of newly acquired HPV …

ABSTRACT A new approach to estimate Genital Warts incidence and prevalence in the
italian general female population. Genital warts (GW), known also as condyloma acuminata …